Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplant in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

NCT00058292 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DRUG: Carmustine
DRUG: cytarabine
DRUG: etoposide
DRUG: melphalan
PROCEDURE: peripheral blood stem cell transplantation
RADIATION: yttrium Y 90 ibritumomab tiuxetan

Sponsor

Northwestern University

Collaborators

[object Object]